Moreover, a tendency for higher expression of TIM3 was observed in CLL groups with stages 1 and 2 compared to stages 3 and 4 (278.8 vs. 130.2, p = 0.0999) (Figure 4b). Here, HAVCR2 is linked to B-cell chronic lymphocytic leukemia.